how trump's covid-19 treatments may impact pharma stocks
Published 4 years ago • 3.7K plays • Length 3:24Download video MP4
Download video MP3
Similar videos
-
4:11
tracking president donald trump's treatment for covid-19
-
3:13
how stocks are moving after trump's covid-19 diagnosis, pelosi suggests positive stimulus talks
-
4:13
how president donald trump's coronavirus diagnosis could affect markets
-
3:50
markets were already vulnerable before president donald trump's covid-19 news: sanchez
-
3:36
jim cramer: don't buy regeneron stock just because trump says its covid-19 antibody cocktail works
-
3:07
is trump’s covid-19 drug treatment making him erratic?
-
6:58
president donald trump using regeneron cocktail was a wholly appropriate call: dr. scott gottlieb
-
trump case live : new twist in trump's investigation| fbi chief christopher a. wray speaks out
-
4:03
gilead ceo on promising study results for remdesivir covid-19 treatment
-
4:21
dr. scott gottlieb says he's surprised trump used regeneron cocktail instead of remdesivir treatment
-
2:46
j.p. morgan's david kelly on market impact from trump's covid-19 diagnosis and stimulus talks
-
2:19
president donald trump spoke with pharmaceutical executives regarding response to covid-19
-
4:18
president donald trump's coronavirus infection seems 'moderate': dr. scott gottlieb
-
12:58
why economic recovery may depend on a coronavirus treatment
-
13:56
coronavirus pandemic update 110: trump's risk factors and covid-19 prognosis; interferon
-
2:16
gilead ceo: we can manufacture enough remdesivir to provide all of the u.s.
-
1:36
stocks tumble after president donald trump tests positive for coronavirus
-
0:57
debunking donald trump's lies about the u.s. economy
-
4:52
the search for a coronavirus treatment
-
3:52
how does experimental covid-19 treatment trump received work? | nbc news
-
6:30
top pharma analyst and investor on timing and effectiveness of a potential covid vaccine
-
2:54
health-care analyst explains how big pharma is approaching coronavirus crisis